by admin | Jan 17, 2022 | Insights
A fantastic primer via Psychedelic Spotlight on the January 5 regulatory changes to Health Canada’s Special Access Program, and what it means for the future of psychedelic-assisted therapy in...
by admin | Jan 17, 2022 | Insights
Big news out of Canada this week: Health Canada, the country’s Federal health policy regulator, has given the green light for psychedelic drugs such as MDMA and magic mushrooms to be used for medical purposes. Health care advocates are calling it a major...
by admin | Jan 13, 2022 | Insights
“It’s safer, Dr. Hutson said, to try psilocybin as part of a study than on your own or in one of the treatment clinics that have popped up. In these trials, patients attend appointments to prepare for and process their psychedelic trip with a professional in an...
by admin | Jan 13, 2022 | Insights
#ICYMI: “I think psychedelics are the difference between knowing something and then really absorbing it and feeling it.”A moving interview in Newsweek with Kirk Rutter, a participant in Imperial College London’s pioneering 2016 study which assessed...
by admin | Jan 6, 2022 | Insights
We are pleased to see some of the advancements in medical psychedelic research included in this round-up of remarkable health discoveries last year. Here’s to more in 2022! #psychedelics #psychedelicscience #psilocybin #psychedelictherapy #clinicaltrials Link to...
by admin | Jan 6, 2022 | Insights
The latest episode of Australian Broadcasting Corporation (ABC) News’ “All in the Mind” delves into the “psychedelic renaissance” and the most recent research in the space. This episode features interviews with Dr. Rick Doblin, Professor...
Recent Comments